
    
      Eligible patients that provide written informed consent will undergo apheresis to collect
      blood mononuclear cells for vaccine production. All patients will receive mature dendritic
      cells for a total of 12 vaccine doses.The DC vaccine will be given subcutaneously every four
      weeks. Peripheral blood will be taken two weeks after injection each time to monitor the
      immune response.
    
  